Showing results (1141-1150 of 1,149) with videos related to
Sort By:
Pageof 115
You have reached the last page of results.This site can display upto 1,149 results.
Journal of Hepatocellular Carcinoma|August 25, 2026
Shikonin in Hepatocellular Carcinoma: Bridging Metabolic Disruption and ImmunomodulationYongjing Dong, Meimei Wang, Ying Cao, et al.Journal of Hepatocellular Carcinoma|September 5, 2026
Development of a PNI-Based Prognostic Model for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib-Based Triple TherapyWeifu Liu, Bohua Yu, Fuqun Wei, et al.Journal of Hepatocellular Carcinoma|September 16, 2026
FOLFOX-HAIC Plus Lenvatinib and Tislelizumab in Advanced Hepatocellular Carcinoma with Arteriovenous Fistulae: A Real-World StudyPengen Li, Shumin Fu, Xiao Wang, et al.Journal of Hepatocellular Carcinoma|September 27, 2026
Gut Microbiota in Hepatocellular Carcinoma: Etiology-Specific Evidence, Mechanisms, and Translational ChallengesXiaohuan GuanJournal of Hepatocellular Carcinoma|October 1, 2026
DEB-TACE Combined with Immunotherapy and Targeted Therapy for Advanced Hepatocellular Carcinoma with Scapular Metastasis: A Case ReportWenxia Zhang, Dongxu Kang, Qiang Xu, et al.Journal of Hepatocellular Carcinoma|October 24, 2026
Prognostic Implications of Nitrogen Metabolism-Related Gene SMS in Hepatocellular Carcinoma: An Integrated Bioinformatics and Experimental ResearchTianyi Gong, Ce Guo, Heng Wang, et al.Journal of Hepatocellular Carcinoma|October 24, 2026
The Efficacy and Safety of Combined Locoregional and Systemic Therapy versus Systemic Therapy Alone in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis: A Multicenter Real-World Retrospective Cohort StudyJianwei Liu, Yuxuan Lin, Kongying Lin, et al.Journal of Hepatocellular Carcinoma|October 24, 2026
MRI-Based Radiomics Predicts FAP Expression and Immunosuppressive Tumor Microenvironment in Hepatocellular CarcinomaRuolian Gao, Guangjie Han, Qi Wang, et al.Journal of Hepatocellular Carcinoma|October 30, 2026
Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative ReviewJin Li, Jin-Yi Zhou, Yue Yu, et al.Pageof 115